San Francisco, California
London, United Kingdom
Affliation: Vanderbilt Brain Institute
Professional Title(s): Director, Vanderbilt Genetics Institute; Director, Division of Genetic Medicine; and, Mary Phillips Edmonds Gray Professor of Genetics
Abstract: I will describe a variety of data integration strategies we are using at Vanderbilt University Medical Center, including strategies that iterate between electronic health records (EHRs) in 2.6 million subjects and the 225,000 on which we have DNA, strategies that allow us to combine information on genome variation with reference transcriptome data in applications to EHRs, and how these integrative strategies pave the way for more efficient implementation trials.
Biography: Nancy J. Cox, PhD, is a quantitative human geneticist with a long-standing research program in identifying and characterizing the genetic component to common diseases and related quantitative traits. She received her undergraduate degree in biology from the University of Notre Dame in 1978, her PhD in Human Genetics from Yale University in 1982, and did post-doctoral research at Washington University and the University of Pennsylvania before moving to the University of Chicago in 1987 to start her academic career. Dr. Cox spent 28 years at the University of Chicago where she was Professor and Chief of the Section of Genetic Medicine when she moved to Vanderbilt University in 2015 to become the Mary Phillips Edmonds Gray Professor of Genetics and Director of the Vanderbilt Genetics Institute, and the Division of Genetic Medicine.
To read more about Ramy Arnaout’s research, please visit: Google Scholar – Nancy Cox, PhD
Save This Event
When & Where
The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations are united in this unprecedented collaboration of technology, science, and medicine.
We implement advanced genomic research, and integrate our findings with world-class technologies and physician-scientists in order to help solve diseases. We harness the diversity of New York’s institutions and people to drive scientific discoveries that will vastly improve clinical care — ethically, equitably and urgently.
We advocate and educate, sharing our findings with the global scientific, medical and thought leadership communities to broaden the reach of the New York Genome Center to help patients in every corner of the world. We create synergies through collaboration to continually innovate and advance our vision.